Tuesday, July 24, 2007

Treating Dupuytren's disease

There's some correlation between Peyronie's disease and Dupuytren's contracture, though the structures involved are fairly different. So this treatment for Dupuytren's, a disorder for which there's been no good treatment, is at least of passing interest:
Straightening Bent Fingers, No Surgery Required - New York Times

Keith Felcyn, a retired senior editor of BusinessWeek magazine who lives in Greenwich, Conn., had not been able to fully extend the little and ring fingers of his left hand for 20 years. But last month, it took 20 minutes for a doctor in Ontario, Ore., to reverse his Dupuytren’s disease, a benign but ultimately disabling disorder in which the fascia of the hand thickens and draws the fingers permanently into the palm.

The disabling disorder causes patients’ fingers to become fixed in a bent position.

“When he finished and I could lay my hand flat,” Mr. Felcyn recalled, “I said, ‘My God, this is a miracle.’ ”

The procedure, called needle aponeurotomy or percutaneous fasciotomy, involves using the bevel of a hypodermic needle to essentially shred the ropes of constricting fascia characteristic of Dupuytren’s disease. The disorder, named for Baron Guillaume Dupuytren, a 19th-century French surgeon who wrote about it, afflicts up to 25 percent of people over 40 in Western countries and is most common in men of northern European descent. Ronald Reagan had it; so does Margaret Thatcher. Risk factors for the disease include hand or wrist trauma, repetitive strain, alcoholism, smoking and diabetes.

Needle aponeurotomy, which leaves only superficial puncture wounds, was developed 30 years ago by a group of French rheumatologists and is now being practiced in the United States by fewer than a dozen physicians. Thousands of patients like Mr. Felcyn are flocking to these doctors every year, many against the advice of hand surgeons who say open hand surgery is more effective.

“Surgery has a lower recurrence rate,” said Dr. Richard Gelberman, chairman of the department of orthopedics at Washington University in St. Louis, and president of the American Society for Surgery of the Hand. The recurrence rate for needle aponeurotomy is around 50 percent after three years, according to several studies published in French medical journals. Studies in the British and American medical literature indicate that the recurrence rate for fasciectomy, or surgical removal of the diseased fascia, is 40 percent after five years.

But surgery carries a significantly higher risk of complications like nerve and vascular injury, infection, inflammation and something called a flare reaction in which the hand gets very swollen, red and stiff.

“Fasciectomy is a delicate procedure that requires meticulous technique,” said Dr. Steven Z. Glickel, director of the C.V. Starr Hand Surgery Center at St. Luke’s-Roosevelt Hospital Center in New York. Moreover, he added, “Patients have to be committed to physical therapy” for six weeks to four months before they can expect to regain full function of the hand.

Mr. Felcyn played tennis the day after his needle aponeurotomy, which, unlike surgery, can be easily repeated should he have a recurrence.

Dr. David Kline, who performed the procedure using a mild local anesthetic, had the same thing done to both his hands five years earlier in France.

“I cried the day I had it done,” Dr. Kline said. “I was so happy to be able to use my hands.” As an emergency room doctor, he had thought his career was over until an Internet search turned up a group of rheumatologists at the Hôpital Lariboisière in Paris offering an alternative to surgery.

Dr. Kline paid 40 euros, about $55, to undergo the procedure. He returned to Paris in 2005 to receive training in the technique. Dr. Kline said he had since performed more than 600 needle aponeurotomies, in addition to continuing to practice emergency medicine, at Holy Rosary Medical Center, in Ontario, Ore.

There is little competition because so few doctors offer it in the United States; a list can be found at http://www.dupuytren-online.info/needle-aponeurotomy.html.

The cost is $500 to $650 per affected finger and is covered by Medicare.

Dr. Charles Eaton, a hand surgeon in Jupiter, Fla., said the technique had been slow to gain acceptance by other American surgeons because “it sounds crazy to work on the delicate structures of the hand without cutting it open to see what you are doing,” especially when Dupuytren’s disease often distorts the anatomy of the hand.

But because patients are awake for the procedure, he said they can report a tingling sensation if the one-half millimeter needle gets too close to a nerve, and they can move their fingers to reveal the location of tendons.

“It took a long time for arthroscopy to take hold, too,” Dr. Eaton said.
It would be interesting to understand exactly how and why this works. I was surprised by the cited prevalence for Dupuytren's. If it's really that common (25%?! of all men over 40?) then any historic association with Peyronie's may be completely coincidental.

Update 8/4/07: The prevalence of contractures is not 25%. Amongst Caucasian European males over age 40 it's probably 1-4%, and maybe 5%+ in Scandinavians.

Friday, July 6, 2007

Proteomics in Peyronie's Disease - including a review of gene profiling in PD

This article isn't published yet, the abstract is from an electronic preprint:
Is There a Role for Proteomics in Peyronie's Disea...[J Sex Med. 2007] - PubMed Result

...This review assesses the potential use of protein alterations measured by various novel technologies, to predict progression, regression, or stabilization of PD in an affected individual. Methods. A comprehensive literature review of the past decade in the field of gene profiling and protein expression of PD was performed...
As I wrote a couple of days ago, even an area as understudied as Peyronie's can advance quickly when new instruments are brought to bear on old questions. Proteomics is all the rage in our post-genomic era, but besides the faddish topic the article claims to have reviewed the full literature on gene profiling in PD (of course that probably took about 3 hours).

This is one article I'm going to have to drag out of the university library -- once it's published!

Another 1960s article on Peyronie's and other "collagen" disorders

This French article from 1964 is the second I've come across discussion combinations of Peyronie's disordr with other disorders of fibrosis ("collagen" in those days): [A COLLAGEN TRIAD: LA PEYRONIE'S DISEASE, DUPUYTRE...[J Urol Nephrol (Paris). 1964]

It's an area of research that died out in the 1960s apparently.

The triad was "PEYRONIE'S DISEASE, DUPUYTREN'S DISEASE AND FIBROSIS OF THE AURICULAR CARTILAGE". I don't know the last, but for what it's worth I used to have odd lumps of fibrous material in my pinnae (soft tissue at base of the auricle) though they've since faded.

It would be interesting to get hold of one of these old, old articles ....

Peyronie's Disease: Type I and Type II?

I've been thinking about the results of a very recent study of the natural history of Peyronie's Disease. I'm thinking the study suggests that there may be two types of Peyronie's disease, early onset (Type I?) and late onset (Type II?) with an age cutoff of 50.

Fifty is a special age. Throughout most of human evolution men did not live past fifty. Nothing is really designed to last that long; life much past fifty requires a cozy environment and, often, some medical care. So things that go wrong after fifty are often normal "wear and tear". That's a clue.

My guess is that Peyronie's after 50 is mostly a bit of bad luck. The course of late onset Peyronie's is relatively benign. Progression is limited. Symptoms may resolve. It sounds more like an unlucky tear or injury to a sub-optimal tunica albuginea than a true disease. It's a vulnerable structure, sometimes it's less well made, it can tear.

Early onset Peyronie's, developing before age 50, is another story. The disease seems to progress, and may do so without evidence of repeated trauma. This seems more like a pathologic process, a genetic disorder of fibrocyte perhaps.

They may be the same condition of course, or related conditions, but I suspect we'll learn more about Peyronie's if we study early onset and late onset disease separately. If we study them together, we may miss important signals in the noise.

Thursday, July 5, 2007

The shared items page - an article from 1965

In a prior post I described how to create feeds to track publication activity in the National Library of Medicine. Since I'm thinking Peyronie's is probably a systemic disorder of fibrocyte function one of my searches tracks articles that focus on both Dupuytren's contractures and Peyronie's disorder. You can see examples of some of those articles on my shared items page.

This is all about catching the latest news, so I was bemused when one of the articles I found was from 1965 ....

It's in German, so not that easy to follow up, but PubMed lets one track related articles, which included this one from 2004:
Qian A et al. Comparison of gene expression...[PMID: 15302515]

... CONCLUSIONS: These data demonstrate that the pattern of alterations in the expression of certain gene families in PD and DD is similar, suggesting that they share a common pathophysiology and may be amenable to the same therapeutic regimens.
Really, not a lot of progress in 40 years, but maybe things will start picking up ...

How to track research developments using syndication and an RSS reader

One of the ways I track research developments is by using an advanced feature of the National Library of Medicine's PubMed database and Google Reader.*

For example, here is a PubMed RSS feed for "fibrocyte disorder" [1]. If you right click on the link to the left, copy and paste it into a feed reader, you'd see a feed.

Here's what I did:
  1. Go to PubMed. (National Library of Medicine, once upon a time a similar product was called 'Grateful Med'. Those were the days.)
  2. Enter your search string (ex. "fibrocyte disorder" and hit enter.
  3. Now, look carefully atop the results for a drop down "button" called "Send To".
  4. Click on "Send To" and choose "RSS Feed".
  5. Now look for the XML icon and copy the link. Paste into Google Reader.
Here's another one, for example, for Peyronie's Disease. It's easy to create as many as you'd like, and the searches can be much more sophisticated than the simple examples above.

One feature of Google Reader is that you can select interesting articles and share those in turn. The page that one uses to share those can be viewed by a web browser, but it also has a feed. Here's the page, which I'll add to over time:
Incidentally, my standing search on Google News also provides RSS syndication, so I'm including that in my Google Groups Peyronie's collection and items I note of interest will be on the shared articles page too. (Actually, at the moment that service appears to be broken ...)
-----------------------
* A discussion of syndication clients is more than I want to get into. Bloglines and Google Reader are two web based clients, Firefox, IE 7 and Safari have reasonably good built-in readers, and their are several good dedicated readers for OS X and one good reader for XP (Onfolio).

[1] One of the ideas I'm exploring is that Peyronie's Disease is really a systemic fibrocyte disorder that manifests as penile deformation because of the unique vascular structure of the tunica albuginea. If so it should have a relationship to other disorders of fibrocyte function...

Wednesday, July 4, 2007

The course of Peyronie's disease

This is just out: The natural history of Peyronie's disease. [Arch Esp Urol. 2007] - PubMed Result. I'll post later on how I get alerts about this kind of thing, but here are the key results from the study of 110 patients over at least five years (based only on the abstract):
1. Patients over 50 tend to stabilize or get better.
2. Patients under 50 tend to get worse. Almost 70% progressed to surgery.
Studies of the natural history of a disorder are hard to fund and hard to do. We need more of them. I don't know how good this one really is, the trick is how representative the initial sample is and how many are lost to follow-up. In general the patients who do worse tend to follow-up, so results of these studies tend to the "grim" side.

Grim is the word for the under-50 group, I really didn't think 70% would end up with surgery. Given that a significant number may have decided to give up on intercourse, it really contradicts the general impression most urologists have about the course of the disorder.

Conversely older patients can do well, though again I wonder how many just decide to give up.

Needless to say, no medical therapy seems to make any difference. Bad numbers, no doubt.